Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design

被引:57
|
作者
Todorov, NP
Dean, PM
机构
[1] Department of Pharmacology, University of Cambridge, Cambridge CB2 1QJ, Tennis Court Road
基金
英国生物技术与生命科学研究理事会; 英国惠康基金;
关键词
simulated annealing; drug design; penalty function optimization; molecular diversity;
D O I
10.1023/A:1008042711516
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We describe an algorithm for the automated generation of molecular structures subject to geometric and connectivity constraints. The method relies on simulated annealing and simplex optimization of a penalty function that contains a variety of conditions and can be useful in structure-based drug design projects. The procedure controls the diversity and complexity of the generated molecules. Structure selection filters are an integral part and drive the algorithm. Several procedures have been developed to achieve reliable control. A number of template sets can be defined and combined to control the range of molecules which are searched. Ring systems are predefined. Normally, the ring-system complexity is one of the most elusive and difficult factors to control when fusion-, bridge- and spiro-structures are built by joining templates. Here this is not an issue; the decision about which systems are acceptable, and which are not, is made before the run is initiated. Queries for inclusion and exclusion spheres are incorporated into the objective function, and, by using a flexible notation,the structure generation can be directed and more focused. Simulated annealing is a reliable optimizer and converges asymptotically to the global minimum. The objective functions used here are degenerate, so it is likely that each run will produce a different set of good solutions.
引用
收藏
页码:175 / 192
页数:18
相关论文
共 50 条
  • [21] PRO-LIGAND - AN APPROACH TO DE-NOVO MOLECULAR DESIGN .4. APPLICATION TO THE DESIGN OF PEPTIDES
    FRENKEL, D
    CLARK, DE
    LI, J
    MURRAY, CW
    ROBSON, B
    WASZKOWYCZ, B
    WESTHEAD, DR
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1995, 9 (03) : 213 - 225
  • [22] AlvaBuilder: A Software for De Novo Molecular Design
    Mauri, Andrea
    Bertola, Matteo
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 64 (07) : 2136 - 2142
  • [23] De novo molecular drug design benchmarking
    Grant, Lauren L.
    Sit, Clarissa S.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (08): : 1273 - 1280
  • [24] De novo molecular design and generative models
    Meyers, Joshua
    Fabian, Benedek
    Brown, Nathan
    DRUG DISCOVERY TODAY, 2021, 26 (11) : 2707 - 2715
  • [25] De novo molecular design: Successes and challenges
    Jorgensen, William L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [26] De novo design of a β-lactamase in a modular helical bundle protein scaffold
    Schneider, Samuel H.
    DeGrado, William
    BIOPHYSICAL JOURNAL, 2022, 121 (03) : 45 - 46
  • [27] The WWdomain as scaffold for de novo design of miniaturized phosphate receptors and phosphatases
    Lindner, Christina
    Thomas, Franziska
    JOURNAL OF PEPTIDE SCIENCE, 2022, 28
  • [28] DE-NOVO DESIGN - LIGAND CONSTRUCTION AND PREDICTION OF AFFINITY
    MARSHALL, GR
    HO, CMW
    OPREA, TI
    WALLER, CL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 37 - COMP
  • [29] Fragment-based de-novo ligand design
    Boehm, HJ
    Roche, HL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 208 - COMP
  • [30] Automated de novo design of ligand responsive RNA devices
    Peters, Gert
    Maertens, Jo
    Lammertyn, Jeroen
    De Mey, Marjan
    NEW BIOTECHNOLOGY, 2016, 33 : S14 - S14